1-(4-fluorophenyl)-1-{2-(pyrazole-1-yl)ethyl}-1,3-dihydro-5-isobenzofurancarbonitrile | 1148028-31-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 异香豆素
• 英文名称: 1-(4-fluorophenyl)-1-{2-(pyrazole-1-yl)ethyl}-1,3-dihydro-5-isobenzofurancarbonitrile
• 英文别名: 1-(4-fluorophenyl)-1-(2-pyrazol-1-ylethyl)-3H-2-benzofuran-5-carbonitrile
• CAS: 1148028-31-2
• 化学式: C₂₀H₁₆FN₃O
• 分子量: 333.365
• InChiKey: PKBWRYPGXOTSMK-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  25
• 可旋转键数：
  4
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  50.8
• 氢给体数：
  0
• 氢受体数：
  4

文献信息

• NOVEL 1,3-DIHYDRO-5-ISOBENZOFURANCARBONITRILE DERIVATIVES AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF PREMATURE EJACULATION
  申请人：Lee Yeong Geon

  公开号：US20100240725A1

  公开（公告）日：2010-09-23

  Disclosed herein are novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives represented by Formula 1, or pharmaceutically acceptable salts thereof. Also disclosed is a pharmaceutical composition for treating or preventing premature ejaculation including the compound. The 1,3-dihydro-5-isobenzofurancarbonitrile derivatives have a short half-life and inhibit the ejaculation process by selectively inhibiting serotonin reuptake via a serotonin reuptake transporter present in a presynaptic neuron. Thus, the compounds are useful in the treatment and prevention of premature ejaculation.

  本文披露了一种新颖的由式1表示的1,3-二氢-5-异苯并呋喃腈衍生物，或其药学上可接受的盐。还披露了一种治疗或预防早泄的药物组合物，包括该化合物。1,3-二氢-5-异苯并呋喃腈衍生物具有短半衰期，并通过选择性地通过存在于突触前神经元中的5-羟色胺再摄取转运体抑制5-羟色胺再摄取来抑制射精过程。因此，这些化合物在早泄的治疗和预防中是有用的。
• US8242159B2
  申请人：——

  公开号：US8242159B2

  公开（公告）日：2012-08-14
• [EN] NOVEL 1,3-DIHYDRO-5-ISOBENZOFURANCARBONITRILE DERIVATIVES AND PHARMACEUTICAL COMPOSITION THEREOF FOR THE TREATMENT OF PREMATURE EJACULATION<br/>[FR] NOUVEAUX DÉRIVÉS DE 1,3-DIHYDRO-5-ISOBENZOFURANCARBONITRILE ET COMPOSITION PHARMACEUTIQUES LES RENFERMANT POUR LE TRAITEMENT DE L'ÉJACULATION PRÉCOCE
  申请人：DONG A PHARM CO LTD

  公开号：WO2009057974A2

  公开（公告）日：2009-05-07

  Disclosed herein are novel l,3-dihydro-5-isobenzofurancarbonitrile derivatives represented by Formula 1, or pharmaceutically acceptable salts thereof. Also disclosed is a pharmaceutical composition for treating or preventing premature ejaculation including the compound. The l,3-dihydro-5-isobenzofurancarbonitrile derivatives have a short half- life and inhibit the ejaculation process by selectively inhibiting serotonin reuptake via a serotonin reuptake transporter present in a presynaptic neuron. Thus, the compounds are useful in the treatment and prevention of premature ejaculation.